Related Experiment Video
Updated: Apr 3, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Fatal Insulin Overdoses: Case Report and Update on Testing Methodology
Nick Sunderland1, Sophia Wong1, Carol K Lee2
1University of British Columbia, Vancouver, BC, Canada.
Journal of Forensic Sciences
|September 25, 2015
Summary
Fatal insulin overdose deaths are rare and difficult to detect. A new mass spectrometry assay accurately measured elevated aspart insulin levels, aiding in diagnosis when other methods failed.
Area of Science:
- Forensic Pathology
- Toxicology
- Endocrinology
Background:
- Suicidal insulin overdose is an under-recognized cause of death.
- Diagnosis often relies on nonspecific autopsy findings and scene investigation.
- Patients with type 1 diabetes are at risk for exogenous insulin administration.
Observation:
- A fatal exogenous insulin overdose case in a type 1 diabetes patient is presented.
- Autopsy findings were non-contributory.
- Serum analog aspart insulin levels were significantly elevated (4000 uU/mL), approximately 10 times the upper therapeutic limit.
Findings:
- A novel immunocapture liquid chromatography-tandem mass spectrometry assay accurately quantified elevated aspart insulin levels.
- This assay could discriminate between various synthetic insulin analogs.
- Standard immunoassays showed variable sensitivity, with one platform detecting elevated levels while another did not.
Implications:
- Highlights the importance of specific assays for detecting synthetic insulin analogs in forensic toxicology.
- Provides guidance on sample collection and analytical options for insulin testing in overdose cases.
- Emphasizes the need for awareness of insulin overdose as a cause of death and relevant autopsy findings.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
1.2K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Insulin: Biosynthesis, Chemistry, and Preparation
2.0K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.0K
Diabetes Mellitus: Overview and Type I Subtype
6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Insulin Formulations: Types and Delivery
1.1K
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
1.1K

